WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced that four presentations of pre-clinical data for its product candidates will take place at the 102nd Annual Meeting of the American Association for Cancer Research, which will be held from April 2-6, 2011 in Orlando, Florida.
